bioRxiv/medRxiv TRiP Review Activity

428 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 31: Articles 301-310  | Next

GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis
Cordova, R., Misra, J., Amin, P. H., Klunk, A. J., Damayanti, N. P., Carlson, K. R., Elmendorf, A. J., Hyeong-Geug, K., Mirek, E. T., Miller, M. J., Dong, X. C., Cheng, L., Anthony, T. G., Pili, R., Wek, R. C., Staschke, K. A.
10.1101/2022.06.17.496598 — Posted: 2022-06-18 — Discussion: 2022-08-12  eLife
Nuclear fascin regulates cancer cell survival
Lawson, C. D., Peel, S., Jayo, A., Corrigan, A., Iyer, P., Baxter Dalrymple, M., Marsh, R. J., Cox, S., Van Audenhove, I., Gettemans, J., Parsons, M.
10.1101/2022.06.17.496538 — Posted: 2022-06-17 — Discussion: 2022-08-02  eLife
The "LINC" in between Δ40p53-miRNA axis in the regulation of cellular processes
Das, S., Pal, A.
10.1101/2022.04.28.489891 — Posted: 2022-04-28 — Discussion: 2022-08-01  Review Commons
Cancer stem cell-derived extracellular vesicles preferentially target MHCII- macrophages and PD1+ T cells in the tumor microenvironment
Gonzalez-Callejo, P., Guo, Z., Ziglari, T., Claudio, N. M., Oshimori, N., Seras-Franzoso, J., Pucci, F.
10.1101/2022.04.26.489579 — Posted: 2022-04-26 — Discussion: 2022-07-12  Review Commons
The scaffolding protein Flot2 regulates cytoneme-based transport of Wnt3 in gastric cancer
Routledge, D., Rogers, S., Ashktorab, H., Phesse, T., Scholpp, S.
10.1101/2022.01.07.475396 — Posted: 2022-01-08 — Discussion: 2022-07-12  eLife
Suppression of endothelial miR-22-3p mediates non-small cell lung cancer cell-induced angiogenesis
Gu, Y., Pais, G., Becker, V., Körbel, C., Ampofo, E., Ebert, E., Hohneck, J., Ludwig, N., Meese, E., Bohle, R. M., Zhao, Y., Menger, M. D., Laschke, M. W.
10.1101/2021.04.04.438401 — Posted: 2021-04-06 — Discussion: 2022-07-09  eLife
DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness
Carrier, A., Desjobert, C., Ponger, L., Lamant, L., Bustos, M., Torres-Ferreira, J., Henrique, R., Jeronimo, C., Lanfrancone, L., Delmas, A., Favre, G., Delaunay, A., Busato, F., Hoon, D. S. B., Tost, J., Etievant, C., Riond, J., Arimondo, P. B.
10.1101/2022.04.11.487909 — Posted: 2022-04-12 — Discussion: 2022-07-07  eLife
Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations
Choudhary, G., Pellagatti, A., Agianian, B., Smith, M., Bhagat, T. D., Gordon-Mitchell, S., Pandey, S., Shah, N., Aluri, S., Schwartz, L., Steeples, V., Booher, R., Ramachandra, M., Samson, M., Carbajal, M., Pradhan, K., Bowman, T., Pillai, M. M., Will, B., Wickrema, A., Shastri, A., Bradley, R. K., Martell, R. E., Steidl, U., Gavathiotis, E., Boultwood, J., Starczynowski, D. T., Verma, A.
10.1101/2022.03.09.483595 — Posted: 2022-03-09 — Discussion: 2022-07-05  eLife
Arbidol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
Liu, K., Dong, Z., Yang, N., Lu, X., Jiang, Y., Zhao, L., Wang, D., Wei, Y., Yu, Y., Kim, M. O., Laster, K. V., Li, X., Yuan, B.
10.1101/2022.02.15.480509 — Posted: 2022-02-18 — Discussion: 2022-06-21  eLife
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
Sipe, L. M., Chaib, M., Korba, E. B., Lovely, M. C., Jo, H., Counts, B. R., Tanveer, U., Clements, J. C., John, N. A., Daria, D., Marion, T. N., Sekhri, R., Pingili, A. K., Teng, B., Carson, J. A., Hayes, D. N., Davis, M. J., Pierre, J. F., Makowski, L.
10.1101/2022.03.30.486293 — Posted: 2022-04-01 — Discussion: 2022-06-16  eLife

Evaluation Sources